Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

A World Without Rebates: Is FDA’s Gottlieb Offering New Vision?

Executive Summary

US FDA Commissioner Gottlieb suggests administrative action to prohibit drug rebates as a way to lower drug prices. His remarks may preview an upcoming proposal from President Trump and HHS Secretary Azar.

You may also be interested in...



‘Legacy’ Drugs And Former US FDA Commissioner Gottlieb’s Legacy

A surprise move to unwind FDA’s efforts to end the marketing of unapproved drugs is in keeping with the overall sense of the top-down intervention in the agency’s policies at the end of the Trump Administration. It is also an unfortunate consequence of the embrace of drug pricing as part of FDA’s mission.

Gottlieb Shifts From Regulatory To Reimbursement Focus In One Of First Post-Commissioner Appearances

CAR-T reimbursement is concern for former US FDA commissioner Scott Gottlieb in speech at the National Press Club.

Trump’s Drug Pricing ‘Dream Team’ And Prospects For Change

“We’re not looking for a lot of turnover. I think we have a team that works very well together,” HHS Deputy Secretary Eric Hargan said.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS123063

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel